FDA Rescinds 2022 Ban on Juul E-Cigarettes, Opens Door for Federal Clearance, Impacting $MO

Jun 6, 2024, 03:18 PM

The U.S. Food and Drug Administration (FDA) has rescinded its 2022 ban on Juul Labs's e-cigarettes. The FDA's decision means that Juul's marketing denial orders from June 2022 are now back to pending and under review. The agency has not yet reached a final determination on whether Juul's products can remain on the U.S. market, but the move opens the possibility for federal clearance. The FDA cited new case law established in lawsuits and further review of Juul's submissions as reasons for the decision. Juul's products have remained on the market pending an appeal of the 2022 ban. This decision impacts companies such as $MO, $BATS, $BTI, and $PM.